Skip to main navigation
Close
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Menu
New White Paper
- Read AAM Report on Drug Shortages
Learn More
Close
Breadcrumb
Association for Accessible Medicines
Resources
Press Releases
Press Releases
Share
Press Release
Sep 6, 2023
| Monét Stanford
Generic and Biosimilar Drugs Generate $408 Billion in Savings For America’s Patients and Health-Care System in 2022
Press Release
Jul 5, 2023
| Susan Reilly
AAM Requests Federal Injunction to Block Minnesota’s Unconstitutional Drug Price Law
Press Release
May 15, 2023
| Susan Reilly
AAM Statement on U.S. Supreme Court Decision to Decline Hearing GSK v. Teva
Press Release
May 11, 2023
| Susan Reilly
4GRxANTED Campaign Generates Millions of Doses of Generic Medicine for Patients in Need
Press Release
Mar 7, 2023
| Susan Reilly
AAM Statement on President Biden's Budget Plan
Press Release
Feb 21, 2023
| Susan Reilly
AAM Announces 2023 Associate Members
Press Release
Feb 16, 2023
| Susan Reilly
AAM Announces 2023 Board of Directors
Press Release
Feb 15, 2023
| Susan Reilly
AAM Statement on CMMI Report
Press Release
Feb 15, 2023
| Susan Reilly
New Social Media Campaign Unveiled to Raise Awareness of the Essential Role of Generic Medicine in Americans’ Lives
Press Release
Feb 13, 2023
| Susan Reilly
Christine Baeder Named Chair of the Association for Accessible Medicines Board of Directors
Press Release
Jan 30, 2023
| Susan Reilly
AAM Applauds CMS for Requiring Health Plans to Place Generic Drugs On Generic Tiers
Press Release
Jan 23, 2023
| Susan Reilly
Study Finds Middlemen Increasingly Block Patient Access to New Generics
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
GRx+Biosims 2022
Access! 2022
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Supply Chain Blueprint
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action